Skip to main content
Erschienen in: Journal of Neural Transmission 3/2017

03.11.2016 | Neurology and Preclinical Neurological Studies - Original Article

A prospective evaluation of taste in Parkinson’s disease

verfasst von: M. J. Ricatti, S. Ottaviani, F. Boschi, A. Fasano, M. Tinazzi, M. P. Cecchini

Erschienen in: Journal of Neural Transmission | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

It is well known that Parkinson’s disease is characterized by a variety of non-motor symptoms. A gustatory deficit is hypothesized to be one of them although few and only cross-sectional studies are available. The aim of our pilot study was to prospectively investigate the taste function in Parkinson’s disease patients after some years from the first evaluation (mean follow-up 4.35 ± 0.49 years; time range 3.5–5.6 years). A group of 26 patients was re-examined (16 males and 10 females; mean age 70.9 ± 8.4 years, range 54–88 years). Taste function was assessed in one session, by means of the Whole Mouth Test (WMT) and Taste Strips Test (TST). Olfaction was also evaluated with the Sniffin’ Sticks Identification Test (SST). All these tests are commercially available (Burghart Company, Germany). All patients were able to understand and complete the procedure. Although scores decreased over time, no significant difference was found between global taste scores of first and second evaluation, neither comparing every single taste quality (WMT: p = 0.234, Mann–Whitney U test; TST: p = 0.747, Mann–Whitney U test; McNemar chi-square in the range of 0–1.455). These results confirm a persistent but slight and stable taste impairment, in patients with Parkinson’s disease. Future studies on a much larger sample of patients are certainly required.
Literatur
Zurück zum Zitat Ahne G, Erras A, Hummel T, Kobal G (2000) Assessment of gustatory function by means of tasting tablets. Laryngoscope 110:1396–1401CrossRefPubMed Ahne G, Erras A, Hummel T, Kobal G (2000) Assessment of gustatory function by means of tasting tablets. Laryngoscope 110:1396–1401CrossRefPubMed
Zurück zum Zitat Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249:1–5CrossRef Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249:1–5CrossRef
Zurück zum Zitat Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M (2014) Taste performance in Parkinson’s disease. J Neural Transm 121:119–122CrossRefPubMed Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M (2014) Taste performance in Parkinson’s disease. J Neural Transm 121:119–122CrossRefPubMed
Zurück zum Zitat Cecchini MP, Fasano A, Boschi F, Osculati F, Tinazzi M (2015) Taste in Parkinson’s disease. J Neurol 262:806–813CrossRefPubMed Cecchini MP, Fasano A, Boschi F, Osculati F, Tinazzi M (2015) Taste in Parkinson’s disease. J Neurol 262:806–813CrossRefPubMed
Zurück zum Zitat Deeb J, Shah M, Muhammed N et al (2010) A basic smell test is a sensitive as dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJMed 103:941–952CrossRef Deeb J, Shah M, Muhammed N et al (2010) A basic smell test is a sensitive as dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJMed 103:941–952CrossRef
Zurück zum Zitat Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB Jr (1991) Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 117:519–528CrossRefPubMed Deems DA, Doty RL, Settle RG, Moore-Gillon V, Shaman P, Mester AF, Kimmelman CP, Brightman VJ, Snow JB Jr (1991) Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 117:519–528CrossRefPubMed
Zurück zum Zitat Doty RL, Nsoesie MT, Chung I, Osman A, Pawasarat I, Caulfield J, Hurtig H, Silas J, Dubroff J, Duda JE, Ying JS, Tekeli H, Leon-Sarmiento FE (2015) Taste function in early stage treated and untreated Parkinson’s disease. J Neurol 262:547–557CrossRefPubMed Doty RL, Nsoesie MT, Chung I, Osman A, Pawasarat I, Caulfield J, Hurtig H, Silas J, Dubroff J, Duda JE, Ying JS, Tekeli H, Leon-Sarmiento FE (2015) Taste function in early stage treated and untreated Parkinson’s disease. J Neurol 262:547–557CrossRefPubMed
Zurück zum Zitat Gilmore MM, Green BG (1993) Sensory irritation and taste produced by NaCl and citric acid: effects of capsaicin desensitization. Chem Senses 18:257–272CrossRef Gilmore MM, Green BG (1993) Sensory irritation and taste produced by NaCl and citric acid: effects of capsaicin desensitization. Chem Senses 18:257–272CrossRef
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway R, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway R, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed
Zurück zum Zitat Haehner A, Hummel T, Reichmann H (2014) A clinical approach towards smell loss in Parkinson’s disease. J Parkinsons Dis 4:189–195PubMed Haehner A, Hummel T, Reichmann H (2014) A clinical approach towards smell loss in Parkinson’s disease. J Parkinsons Dis 4:189–195PubMed
Zurück zum Zitat Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3000 subjects. Eur Arch Otorhinolaryngol 264:237–243CrossRefPubMed Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3000 subjects. Eur Arch Otorhinolaryngol 264:237–243CrossRefPubMed
Zurück zum Zitat Kashihara K, Hanaoka A, Imamura T (2011) Frequency and characteristics of taste impairment in patients with Parkinson’s disease: results of a clinical interview. Intern Med 50:2311–2315CrossRefPubMed Kashihara K, Hanaoka A, Imamura T (2011) Frequency and characteristics of taste impairment in patients with Parkinson’s disease: results of a clinical interview. Intern Med 50:2311–2315CrossRefPubMed
Zurück zum Zitat Kim H-J, Jeon BS, Lee J-Y et al (2011) Taste function in patients with Parkinson’s disease. J Neurol 258:1076–1079CrossRefPubMed Kim H-J, Jeon BS, Lee J-Y et al (2011) Taste function in patients with Parkinson’s disease. J Neurol 258:1076–1079CrossRefPubMed
Zurück zum Zitat Landis BN, Welge-Luessen A, Brämerson A, Bende M, Mueller CA, Nordin S, Hummel T (2009) “Taste Strips”—a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 256:242–248CrossRefPubMed Landis BN, Welge-Luessen A, Brämerson A, Bende M, Mueller CA, Nordin S, Hummel T (2009) “Taste Strips”—a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 256:242–248CrossRefPubMed
Zurück zum Zitat Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, Nordin S, Hummel T (2010) Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol 257:1303–1308CrossRefPubMed Landis BN, Scheibe M, Weber C, Berger R, Brämerson A, Bende M, Nordin S, Hummel T (2010) Chemosensory interaction: acquired olfactory impairment is associated with decreased taste function. J Neurol 257:1303–1308CrossRefPubMed
Zurück zum Zitat Lang CJG, Leuschner T, Ulrich K et al (2006) Taste in dementing diseases and parkinsonism. J Neurol Sci 248:177–184CrossRefPubMed Lang CJG, Leuschner T, Ulrich K et al (2006) Taste in dementing diseases and parkinsonism. J Neurol Sci 248:177–184CrossRefPubMed
Zurück zum Zitat Moberg PJ, Balderston CC, Rick JH, Roalf DR, Weintraub D, Kleiner-Fisman G, Stern MB, Duda JE (2007) Phenylthiocarbamide (PTC) perception in Parkinson disease. Cogn Behav Neurol 20:145–148CrossRefPubMed Moberg PJ, Balderston CC, Rick JH, Roalf DR, Weintraub D, Kleiner-Fisman G, Stern MB, Duda JE (2007) Phenylthiocarbamide (PTC) perception in Parkinson disease. Cogn Behav Neurol 20:145–148CrossRefPubMed
Zurück zum Zitat Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, Kobal G (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed Mueller C, Kallert S, Renner B, Stiassny K, Temmel AF, Hummel T, Kobal G (2003) Quantitative assessment of gustatory function in a clinical context using impregnated “taste strips”. Rhinology 41:2–6PubMed
Zurück zum Zitat Shah M, Deeb J, Fernando M et al (2009) Abnormality of taste and smell in Parkinson’s disease. Parkinsonism Relat Disord 15:232–237CrossRefPubMed Shah M, Deeb J, Fernando M et al (2009) Abnormality of taste and smell in Parkinson’s disease. Parkinsonism Relat Disord 15:232–237CrossRefPubMed
Zurück zum Zitat Sienkiewicz-Jarosz H, Scinska A, Kuran W et al (2005) Taste responses in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:40–46CrossRefPubMed Sienkiewicz-Jarosz H, Scinska A, Kuran W et al (2005) Taste responses in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:40–46CrossRefPubMed
Zurück zum Zitat Sienkiewicz-Jarosz H, Scinska A, Swiecicki L, Lipczynska-Lojkowska W, Kuran W, Ryglewicz D, Kolaczkowski M, Samochowiec J, Bienkowski P (2013) Sweet liking in patients with Parkinson’s disease. J Neurol Sci 329:17–22CrossRefPubMed Sienkiewicz-Jarosz H, Scinska A, Swiecicki L, Lipczynska-Lojkowska W, Kuran W, Ryglewicz D, Kolaczkowski M, Samochowiec J, Bienkowski P (2013) Sweet liking in patients with Parkinson’s disease. J Neurol Sci 329:17–22CrossRefPubMed
Metadaten
Titel
A prospective evaluation of taste in Parkinson’s disease
verfasst von
M. J. Ricatti
S. Ottaviani
F. Boschi
A. Fasano
M. Tinazzi
M. P. Cecchini
Publikationsdatum
03.11.2016
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 3/2017
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-016-1638-y

Weitere Artikel der Ausgabe 3/2017

Journal of Neural Transmission 3/2017 Zur Ausgabe

Psychiatry and Preclinical Psychiatric Studies - Original Article

The differential relationship between trait anxiety, depression, and resting frontal α-asymmetry

High Impact Review in Neuroscience, Neurology or Psychiatry - Review Article

Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation

Neurology and Preclinical Neurological Studies - Original Article

Brain structural profile of multiple system atrophy patients with cognitive impairment

Neurology and Preclinical Neurological Studies - Original Article

Attention in Parkinson’s disease with fatigue: evidence from the attention network test

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.